Table 1. Clinicopathological features and survival.
Patient | Gender | Age (years) | Primary symptom | T (cm) | Stage (TNM) | Histological grade | Treatment strategy | Treatment response | Survival (months) |
---|---|---|---|---|---|---|---|---|---|
1 | Female | 65 | Neck pain | 3.1 | IVc | Moderate | C | NR | 5.5 |
2 | Female | 57 | Hoarseness | 4.1 | IVc | High-moderate | R | NR | 6.5 |
3 | Female | 60 | Neck mass | 3.2 | IVb | Moderate | R + C | PD | 9 |
4 | Male | 79 | Neck mass | 5.0 | IVb | High | R + C | NR | 4.5 |
5 | Male | 61 | Hoarseness | 2.8 | IVb | Moderate-low | S + R | PR | 11.5 |
6 | Male | 38 | Dyspnea | 5.5 | IVc | High | R | NR | 2 |
7 | Male | 62 | No | 2.3 | IVa | Low | S + R + C | PR | 14 |
8 | Male | 59 | Neck mass | 3.3 | IVa | Low | S + R + C | PR | 13 |
9 | Male | 43 | Dysphagia | 4.5 | IVb | Low | S + R | PD | 10 |
10 | Male | 41 | Neck mass | 3.5 | IVa | Low | S + R | PR | 12.5 |
11 | Male | 42 | Neck mass | 4.2 | IVb | Moderate-low | R + C | PR | 11.5 |
12 | Male | 48 | No | 1.8 | IVa | Low | S + R | SD | 18 |
C, chemotherapy; R, radiotherapy; S, surgery; NR, no response; PR, partial response; PD, progressive disease; SD, stable disease.